| |
Skopje, October
2008
|
HIV in South East Europe -
Optimising HIV monitoring technologies
Skopje, R. Macedonia, 10 - 12 October 2008
Chair: Dr Milena Stevanovic, National Coordinator for HIV/AIDS
of the Republic of Macedonia
training | draft
programme | trainers | report
 Suzanne
Crowe,
Australia
Professor Suzanne Crowe has recently
been appointed Head of the Centre for Virology, Burnet Institute,
Melbourne, responsible for approximately 100 scientists and physicians who
investigate HIV, hepatitis and respiratory viruses. She is also
an NHMRC Principal Research Fellow, Principal Specialist in Infectious
Diseases at the Alfred Hospital where she takes care of individuals
with HIV infection, and Professor of Medicine and Infectious Diseases
at Monash University, Melbourne. She is currently an adviser and
consultant to the World Health Organisation Global Program on AIDS,
Deputy Chairman of the Board of the Australian India Council (Department
of Foreign Affairs and Trade) and has served as President of the
Australasian Society for HIV Medicine and as a member of the Prime
Minister’s Science Engineering and Innovation Council Asia
Working Group. Her laboratory has recently been appointed the Regional
WHO Reference laboratory for HIV Resistance testing. With over
180 peer-reviewed publications, her main research interests are
the role of macrophages in HIV pathogenesis and translational research
in low cost CD4 and Viral Load tests to monitor HIV infection in
developing countries. She has organized 41 train-the-trainer programs
on HIV clinical management for doctors working in urban and rural
India, as well as similar training programs in Fiji, Indonesia,
China, and Malaysia. Her laboratory has transferred technology
for performing low cost monitoring tests into each of these countries.
TOP OF PAGE
 Alan
L. Landay PhD,
United States
Dr. Alan Landay is Professor and Chairman of the
Department of Immunology/Microbiology at Rush University Medical
Center in Chicago. He has been involved in HIV research
for over 25 years having performed some of the first immune evaluations
of HIV infected haemophiliacs in 1982 while completing a postdoctoral
fellowship at the University of Alabama, Birmingham. Dr.
Landay joined the faculty at Rush University Medical Center in
1983 and helped establish the HIV research program which has grown
to encompass both a basic and clinical focus on immune studies
in HIV. Dr. Landay served as Chair of the National Committee
of Clinical Laboratory Standards Committee on Flow Cytometry which
produced the first national standard on CD4 testing. He has
also served as an advisor to the College of American Pathologists,
NIH and WHO on Standardization of CD4 Testing and serves on the
Bill and Melinda Gates Foundation Global Health Care Technologies
Committee. Dr. Landay’s current research focus is on
immune pathogenesis and immune based therapy of HIV disease and
he is past Chair of the Immunology Research Agenda Committee of
the AIDS Clinical Trial Group NIH Program and he has served on
the Executive Committee of the Forum for HIV Collaborative Research. Dr.
Landay is Chair of the Office of AIDS Research Panel on Pathogenesis. He
serves on NIH, AmFar, Glazer Pediatric AIDS Foundation and State
of California Grant grant review panels. He has served as
a mentor for over 15 graduate students and postdoctoral fellows
who have gone on to obtain academic positions. Dr. Landay
has published over 250 papers focused on basic and clinical studies
of HIV.
TOP OF PAGE
|
